Apixaban
Apixaban is a generic anticoagulant medication that helps prevent blood clots by inhibiting Factor Xa. Available as 2.5 mg and 5 mg oral tablets, manufactured by Amneal Pharmaceuticals of New York LLC under ANDA209810. This product has been discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Apixaban is a generic anticoagulant medication that helps prevent blood clots by inhibiting Factor Xa. Available as 2.5 mg and 5 mg oral tablets, manufactured by Amneal Pharmaceuticals of New York LLC under ANDA209810. This product has been discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Apixaban",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Apixaban — ANDA 210067 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210067"
}
]
|
| identifier | ANDA210067 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Apixaban |
